Vladimir Vexler - 10 Jan 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Scientific Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Vladimir Vexler
Issuer symbol
CHRS
Transactions as of
10 Jan 2023
Net transactions value
-$72,436
Form type
4
Filing time
12 Jan 2023, 15:37:50 UTC
Previous filing
06 Jan 2023
Next filing
24 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability $35,480 -3,602 -3.7% $9.85 94,925 10 Jan 2023 Direct F1
transaction CHRS Common Stock Tax liability $36,957 -3,602 -3.8% $10.26 91,323 11 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.